Publications by authors named "Daniel Royston"

Claim this Profile
U
Using optical skyrmions to assess vectorial adaptive optics capabilities in the presence of complex aberrations.
Yifei Ma, Zimo Zhao, Yuanxing Shen, Binguo Chen, An Aloysius Wang, Daniel J Royston

Sci Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.
Nicolas Papadopoulos, Audrey Nédélec, Yacine Rahmani, Hosuk Ryou, Jean-Philippe Defour, Daniel Royston

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reconfigurable arbitrary retarder array as complex structured matter.
Chao He, Binguo Chen, Zipei Song, Zimo Zhao, Yifei Ma, Daniel J Royston

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.
Hosuk Ryou, Emily Thomas, Marta Wojciechowska, Laura Harding, Ka Ho Tam, Daniel Royston

EJHaem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential.
Rosalin A Cooper, Emily Thomas, Anna M Sozanska, Carlo Pescia, Daniel J Royston

Leukemia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.
Anna L Godfrey, Nikolaos Sousos, Rebecca Frewin, Mahesh Prahladan, Anna C Green, Daniel Royston

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
Rong Li, Michela Colombo, Guanlin Wang, Antonio Rodriguez-Romera, Camelia Benlabiod, Daniel Royston

Sci Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa.
Hosuk Ryou, Korsuk Sirinukunwattana, Ruby Wood, Alan Aberdeen, Jens Rittscher, Daniel Royston

Hemasphere· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal myeloid sarcoma as a manifestation of acute monomyelocytic leukaemia.
Arbaaz Pervaiz, Marina Brimioulle, Ali Qureishi, Daniel Royston

BMJ Case Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative interpretation of bone marrow biopsies in MPN-What's the point in a molecular age?
Hosuk Ryou, Oliver Lomas, Helen Theissen, Emily Thomas, Jens Rittscher, Daniel Royston

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.
Hosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, Gillian Grindstaff, Bernadette J Stolz, Daniel Royston

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.
Hosuk Ryou, Korsuk Sirinukunwattana, Alan Aberdeen, Gillian Grindstaff, Bernadette J Stolz, Daniel Royston

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
Tariq I Mughal, Naveen Pemmaraju, Rafael Bejar, Robert P Gale, Prithviraj Bose, Daniel Royston

Hematol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.
Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun, Kubra Karagoz, Ann Polonskaia, Daniel Royston

Blood· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Scale Graphical Representation of Cell Environment.
Helen Theissen, Tapabrata Chakraborty, Stefano Malacrino, Daniel Royston, Jens Rittscher

Annu Int Conf IEEE Eng Med Biol Soc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In utero origin of myelofibrosis presenting in adult monozygotic twins.
Nikolaos Sousos, Máire Ní Leathlobhair, Christina Simoglou Karali, Eleni Louka, Nicola Bienz, Daniel Royston

Nat Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of Castleman disease.
Oliver C Lomas, Matthew Streetly, Guy Pratt, Jim Cavet, Daniel Royston

Br J Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning Cellular Phenotypes through Supervision.
Helen Theissen, Tapabrata Chakraborti, Stefano Malacrino, Korsuk Sirinukunwattana, Daniel Royston

Annu Int Conf IEEE Eng Med Biol Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
Stephen W Booth, Toby A Eyre, John Whittaker, Leticia Campo, Lai Mun Wang, Daniel Royston

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.
Daniel Royston, Adam J Mead, Bethan Psaila

Hematol Oncol Clin North Am· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients.
Korsuk Sirinukunwattana, Alan Aberdeen, Helen Theissen, Nikolaos Sousos, Bethan Psaila, Daniel Royston

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.
John Willan, Andrew J King, Faouzi Djebbari, Gareth D H Turner, Daniel J Royston

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.
Bethan Psaila, Guanlin Wang, Alba Rodriguez-Meira, Rong Li, Elisabeth F Heuston, Daniel Royston

Mol Cell· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Toby A Eyre, Catherine Hildyard, Angela Hamblin, Ayesha S Ali, Aimee Houlton, Daniel Royston

Hematol Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology.
Richard Colling, Daniel Royston, Elizabeth Soilleux

J Hematop· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis